| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Interim CEO, COO &CFO | COO &Chief Financial Officer
2 companies
Lowe Christopher P. is an Interim CEO, COO &CFO at Quince Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 10 sells.
Estimated insider holdings value: $251K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2022 | VINC Vincerx Pharma, Inc. | Director | Buy | 30,000 | $1.65 | $49,438.12 | +78.1% | - | - | |
| Oct 5, 2021 | QNCX Quince Therapeutics, Inc. | COO &Chief Financial Officer | Sale+OE | 4,963 | $98.50 | $488,855.50 | -7.6% | -86.2% | -98.7% | |
| Aug 16, 2021 | QNCX Quince Therapeutics, Inc. | COO &Chief Financial Officer | Sale+OE | 22,000 | $95.31 | $2,096,778.94 | -11.2% | -84.4% | -97.7% | |
| Jun 30, 2021 | VINC Vincerx Pharma, Inc. | Director | Buy | 10,000 | $12.62 | $126,152.00 | +156.3% | - | - | |
| Jun 28, 2021 | QNCX Quince Therapeutics, Inc. | COO &Chief Financial Officer | Sale+OE | 20,000 | $54.15 | $1,083,073.50 | -51.9% | +72.2% | -95.8% |